id: NEW:neonatal_probiotic_supplementation_to_NEW:neonatal_sepsis
name: Neonatal Probiotic Supplementation â†’ Neonatal Sepsis
from_node:
  node_id: NEW:neonatal_probiotic_supplementation
  node_name: Neonatal Probiotic Supplementation
to_node:
  node_id: NEW:neonatal_sepsis
  node_name: Neonatal Sepsis
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Probiotic supplementation introduces beneficial bacterial strains to the
  neonatal gastrointestinal tract during the critical colonization period'
- 'Step 2: Beneficial bacteria competitively exclude pathogenic organisms by occupying
  attachment sites on intestinal epithelium and competing for nutrients'
- 'Step 3: Probiotics enhance intestinal barrier function, reducing bacterial translocation
  from the gut lumen into the bloodstream'
- 'Step 4: Probiotics modulate the neonatal immune system, enhancing both innate and
  adaptive immune responses against pathogens'
- 'Step 5: Reduced pathogen colonization and improved immune function lead to decreased
  incidence of systemic bacterial infection (sepsis)'
evidence:
  quality_rating: A
  n_studies: 21
  primary_citation: 'A. Imdad et al. 2021. Effects of neonatal nutrition interventions
    on neonatal mortality and child health and development outcomes: A systematic
    review. Campbell Systematic Reviews.'
  supporting_citations: []
description: Probiotic supplementation during the neonatal period reduces the risk
  of neonatal sepsis by 22% (RR 0.78, 95% CI 0.70-0.86) based on high-quality evidence
  from 21 randomized controlled trials with 9,105 participants. The number needed
  to treat to prevent one case of sepsis is 14. This protective effect is observed
  primarily in preterm and low birth weight neonates in hospital settings in low-
  and middle-income countries.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.78
    type: relative_risk
    ci_lower: 0.7
    ci_upper: 0.86
  p_value: null
  sample_size: 9105
moderators:
- name: gestational_age
  direction: strengthens
  strength: moderate
  description: Most studies focused on preterm neonates (<37 weeks gestation), suggesting
    greater benefit in this vulnerable population
- name: birth_weight
  direction: strengthens
  strength: moderate
  description: Studies primarily included low birth weight infants (<2500g), indicating
    enhanced protective effects in this group
- name: setting
  direction: strengthens
  strength: moderate
  description: Evidence primarily from hospital/NICU settings; community setting evidence
    lacking
